title: DNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat.
abstract: Inflammatory Bowel Diseases (IBD), including Crohn's Disease and Ulcerative Colitis, have long been associated with a genetic basis, and more recently host immune responses to microbial and environmental agents. Dinitrobenzene sulfonic acid (DNBS)-induced colitis allows one to study the pathogenesis of IBD associated environmental triggers such as stress and diet, the effects of potential therapies, and the mechanisms underlying intestinal inflammation and mucosal injury. In this paper, we investigated the effects of dietary n-3 and n-6 fatty acids on the colonic mucosal inflammatory response to DNBS-induced colitis in rats. All rats were fed identical diets with the exception of different types of fatty acids [safflower oil (SO), canola oil (CO), or fish oil (FO)] for three weeks prior to exposure to intrarectal DNBS. Control rats given intrarectal ethanol continued gaining weight over the 5 day study, whereas, DNBS-treated rats fed lipid diets all lost weight with FO and CO fed rats demonstrating significant weight loss by 48 hr and rats fed SO by 72 hr. Weight gain resumed after 72 hr post DNBS, and by 5 days post DNBS, the FO group had a higher body weight than SO or CO groups. Colonic sections collected 5 days post DNBS-treatment showed focal ulceration, crypt destruction, goblet cell depletion, and mucosal infiltration of both acute and chronic inflammatory cells that differed in severity among diet groups. The SO fed group showed the most severe damage followed by the CO, and FO fed groups that showed the mildest degree of tissue injury. Similarly, colonic myeloperoxidase (MPO) activity, a marker of neutrophil activity was significantly higher in SO followed by CO fed rats, with FO fed rats having significantly lower MPO activity. These results demonstrate the use of DNBS-induced colitis, as outlined in this protocol, to determine the impact of diet in the pathogenesis of IBD.
authors.affiliation: Division of Gastroenterology, BC Children's Hospital.
authors.forename: Vijay
authors.initials: V
authors.lastname: Morampudi
authors.affiliation: Division of Gastroenterology, BC Children's Hospital.
authors.forename: Ganive
authors.initials: G
authors.lastname: Bhinder
authors.affiliation: Division of Gastroenterology, BC Children's Hospital.
authors.forename: Xiujuan
authors.initials: X
authors.lastname: Wu
authors.affiliation: Division of Gastroenterology, BC Children's Hospital.
authors.forename: Chuanbin
authors.initials: C
authors.lastname: Dai
authors.affiliation: Division of Gastroenterology, BC Children's Hospital.
authors.forename: Ho Pan
authors.initials: HP
authors.lastname: Sham
authors.affiliation: Division of Gastroenterology, BC Children's Hospital.
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Vallance
authors.affiliation: Division of Gastroenterology, BC Children's Hospital; kjacobson@cw.bc.ca.
authors.forename: Kevan
authors.initials: K
authors.lastname: Jacobson
mesh_terms: D000818:Animals; D003092:Colitis / Q000139:chemically induced* / Q000473:pathology*; D004041:Dietary Fats / Q000008:administration & dosage*; D004139:Dinitrofluorobenzene / Q000031:analogs & derivatives*; D004195:Disease Models, Animal; D005260:Female; D015212:Inflammatory Bowel Diseases / Q000139:chemically induced* / Q000473:pathology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D017207:Rats, Sprague-Dawley; D014302:Trinitrobenzenesulfonic Acid
chemical_list: D004041:Dietary Fats; C045305:2,4-dinitrofluorobenzene sulfonic acid; D014302:Trinitrobenzenesulfonic Acid; D004139:Dinitrofluorobenzene